Clinicopathologic pattern in electrophoresis with a special reference to M-Spike-a hospital based study.
Project Description
Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.
Project Duration
2020 - 2022
Project Lead
Dr Rhea Orathi Pathangi
Authors
Dr Rhea Orathi Pathangi, Dr Jyothi D N, Dr Anitha Devanath
Project Status
completed
Project Type
Student Project